Glibenclamide induces apoptosis through inhibition of cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels and intracellular Ca2+ release in HepG2 human hepatoblastoma cells

Biochemical and Biophysical Research Communications

Volumn 261, Issue 3, 1999, Pages 682-688

  Kim, Jung Ae ^a   Kang, Young Shin ^b   Lee, Sun Hee ^b   Lee, Eun Hee ^a   Yoo, Byong Hoon ^a   Lee, Yong Soo ^b  

^a Yeungnam University   (South Korea)

^b Catholic Kwandong University   (South Korea)

Author keywords

Apoptosis; Cystic fibrosis transmembrane conductance regulator; Glibenclamide; Intracellular Ca2+; Intracellular Cl

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; CALCIUM CHELATING AGENT; CALCIUM ION; CHLORIDE CHANNEL; CHLORIDE ION; DANTROLENE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLIBENCLAMIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033546717     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1108     Document Type: Article

References (34)

1. Jordan V. C. Breast Cancer Res. Treat. 15:1990;125-136.
2. Nayfield S. G., Karp J. E., Ford L. G., Dorr F. A., Kramer B. S. J. Natl. Cancer. Inst. 83:1991;1450-1459.
3. Schulte-Hermann R., Bursch W., Low-Baselli A., Wagner A., Grasl-Kraupp B. Cell. Biol. Toxicol. 13:1997;339-348.
4. Kastan M. B., Canman C. E., Leonard C. J. Cancer Metastasis Rev. 14:1995;3-15.
5. Kornblau S. M. Leukemia. 12:1998;S41-46.
6. Kamesaki H. Int. J. Hematol. 68:1998;29-43.
7. Crompton N. E. Acta Oncol. 37:1998;1-49.
8. Kelley K. A., Stamm S., Kozak C. A. Genomics. 13:1992;381-388.
9. Aitken M. L. Curr. Opin. Pulm. Med. 2:1996;435-438.
10. Maiuri L., Raia V., De Marco G., Coletta S., de Ritis G., Londei M., Auricchio S. FEBS Lett. 408:1997;225-231.
11. Gottlieb R. A., Dosanjh A. Proc. Natl. Acad. Sci. USA. 93:1996;3587-3591.
12. Sheppard D. N., Robinson K. A. J. Physiol. (Lond). 503:1997;333-346.
13. McConkey D. J., Orrenius S. J. Leukoc. Biol. 59:1996;775-783.
14. Hockenbery D., Nunez G., Milliman C., Schreiber R. D., Korsmeyer S. J. Nature. 348:1990;334-336.
15. Bombeli T., Karsan A., Tait J. F., Harlan J. M. Blood. 89:1997;2429-2442.
16. Verkman A. S., Sellers M. C., Chao A. C., Leung T., Ketcham R. Anal. Biochem. 178:1989;355-361.
17. West M. R., Molloy C. R. Anal. Biochem. 241:1996;51-58.
18. Shumaker H., Amlal H., Frizzell R., Ulrich C. D. Jr., Soleimani M. Am. J. Physiol. 276:1999;C16-25.
19. Seligmann B. E., Gallin J. I. J. Clin. Invest. 66:1980;493-503.
20. Luzi L., Pozza G. Acta Diabetol. 34:1997;239-244.
21. Bray K. M., Quast U. J. Biol. Chem. 267:1992;11689-11692.
22. Becq F., Verrier B., Chang X. B., Riordan J. R., Hanrahan J. W. J. Biol. Chem. 271:1996;16171-16179.
23. Dawson D. C., Smith S. S., Mansoura M. K. Physiol. Rev. 79:1999;S47-75.
24. Sood R., Bear C., Auerbach W., Reyes E., Jensen T., Kartner N., Riordan J. R., Buchwald M. EMBO J. 11:1992;2487-2494.
25. Wondergem R., Cregan M., Strickler L., Miller R., Suttles J. J. Membr. Biol. 161:1998;257-262.
26. Woodfork K. A., Wonderlin W. F., Peterson V. A., Strobl J. S. J. Cell Physiol. 162:1995;163-171.
27. Schultz B. D., Singh A. K., Devor D. C., Bridges R. J. Physiol. Rev. 79:1999;S109-S144.
28. Harman A. W., Maxwell M. J. Annu. Rev. Pharmacol. Toxicol. 35:1995;129-144.
29. Exton J. H. Adv. Exp. Med. Biol. 400A:1997;3-8.
30. Rubalcava B., Grajales M. O., Cerbon J., Pliego J. A. Biochim. Biophys. Acta. 759:1983;243-249.
31. Kong S. K., Choy Y. M., Fung K. P., Lee C. Y. Second Messengers Phosphoproteins. 13:1991;117-130.
32. Zhang G. H., Melvin J. E. Cell Calcium. 14:1993;551-562.
33. Pittet D., Di Virgilio F., Pozzan T., Monod A., Lew D. P. J. Biol. Chem. 265:1990;14256-14263.
34. Ismailov I. I., Awayda M. S., Jovov B., Berdiev B. K., Fuller C. M., Dedman J. R., Kaetzel M., Benos D. J. J. Biol. Chem. 271:1996;4725-4732.